المؤلفون: Al Rabayah A; Center for Drug Policy and Technology Assessment (CDPTA), Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research, and Health Technology Assessment, UMIT TIROL-University for Health Sciences and Technology, Hall i.T., Austria. Electronic address: arabaiah@khcc.jo., Al Froukh R; Center for Drug Policy and Technology Assessment (CDPTA), Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan., Sawalha R; Center for Drug Policy and Technology Assessment (CDPTA), Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan., Al Shnekat M; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan., Jahn B; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research, and Health Technology Assessment, UMIT TIROL-University for Health Sciences and Technology, Hall i.T., Austria., Siebert U; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research, and Health Technology Assessment, UMIT TIROL-University for Health Sciences and Technology, Hall i.T., Austria; Division of Health Technology Assessment, ONCOTYROL, Center for Personalized Cancer Medicine, Innsbruck, Austria; Center for Health Decision Science, Departments of Epidemiology and Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Jaddoua SM; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.

المصدر: Value in health regional issues [Value Health Reg Issues] 2024 Sep; Vol. 43, pp. 101004. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101592642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-1102 (Electronic) Linking ISSN: 22121099 NLM ISO Abbreviation: Value Health Reg Issues Subsets: MEDLINE

مواضيع طبية MeSH: Pemetrexed*/therapeutic use , Pemetrexed*/economics , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/economics , Cost-Benefit Analysis*/methods , Quality-Adjusted Life Years* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/economics , Markov Chains*, Humans ; Jordan ; Female ; Male ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/economics ; Middle Aged

المؤلفون: Fang W; Department of Respiratory, Nan'an District People's Hospital, Chongqing, 400060, China., Peng X; Comprehensive Cancer Center, Daping Hospital, Army Medical University, No. 10 Daping Changjiang branch Road, Yuzhong District, Chongqing, 400042, China. sorgofang@163.com., Zhou Q; Department of Respiratory, Nan'an District People's Hospital, Chongqing, 400060, China.

المصدر: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Aug 02; Vol. 19 (1), pp. 478. Date of Electronic Publication: 2024 Aug 02.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101265113 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-8090 (Electronic) Linking ISSN: 17498090 NLM ISO Abbreviation: J Cardiothorac Surg Subsets: MEDLINE

مواضيع طبية MeSH: Pemetrexed*/therapeutic use , Pemetrexed*/administration & dosage , Bevacizumab*/therapeutic use , Bevacizumab*/administration & dosage , Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy , Lung Neoplasms*/mortality, Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Treatment Outcome ; Randomized Controlled Trials as Topic

المؤلفون: P BS; Department of Biochemistry, Vivekanandha College of Arts and Sciences for Women (Autonomous), Tiruchengode, Namakkal, Tamilnadu, India., Periasamy T; Department of Biochemistry, Muthayammal College of Arts and Science (Autonomous), Namakkal, India., Alarfaj AA; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia., Arulselvan P; Department of Chemistry, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India., Ravindran R; Preclinical Department, Faculty of Medicine, Universiti Kuala Lumpur, Royal College of Medicine Perak, Ipoh, Malaysia., Suriyaprakash J; Guangdong Provincial Key Laboratory of Nanophotonic Functional Materials and Devices, School of Information and Optoelectronic Science and Engineering, South China Normal University, Guangzhou, China., Thangavelu I; Department of Chemistry, CHRIST (Deemed to be University), Bangalore, India.

المصدر: Biotechnology and applied biochemistry [Biotechnol Appl Biochem] 2024 Aug; Vol. 71 (4), pp. 779-790. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8609465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1470-8744 (Electronic) Linking ISSN: 08854513 NLM ISO Abbreviation: Biotechnol Appl Biochem Subsets: MEDLINE

مواضيع طبية MeSH: Gold*/chemistry , Gold*/pharmacology , Metal Nanoparticles*/chemistry , Apoptosis*/drug effects , Reactive Oxygen Species*/metabolism , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Mitochondria*/drug effects , Mitochondria*/metabolism , Pemetrexed*/pharmacology , Pemetrexed*/chemistry , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry, Humans ; Cell Survival/drug effects ; A549 Cells ; Drug Screening Assays, Antitumor ; Cell Proliferation/drug effects ; Dose-Response Relationship, Drug ; Cell Line, Tumor

المؤلفون: Mohajeri M; Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin 1983963113 Tehran, Iran., Salehi P; Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin 1983963113 Tehran, Iran., Heidari B; Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin 1983963113 Tehran, Iran., Rafati H; Department of Pharmaceutical Engineering, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, 1983963113 Tehran, Iran., Asghari SM; Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 13145-1384, Iran., Behboudi H; Department of Biology, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, 1983963113 Tehran, Iran., Iranpour P; Medical Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz 71936-13311, Iran.

المصدر: ACS applied bio materials [ACS Appl Bio Mater] 2024 Sep 16; Vol. 7 (9), pp. 5977-5991. Date of Electronic Publication: 2024 Aug 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: ACS Publications Country of Publication: United States NLM ID: 101729147 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2576-6422 (Electronic) Linking ISSN: 25766422 NLM ISO Abbreviation: ACS Appl Bio Mater Subsets: MEDLINE

مواضيع طبية MeSH: Gold*/chemistry , Polyethylene Glycols*/chemistry , Metal Nanoparticles*/chemistry , Contrast Media*/chemistry , Pemetrexed*/chemistry , Pemetrexed*/pharmacology , Materials Testing* , Tomography, X-Ray Computed* , Biocompatible Materials*/chemistry , Biocompatible Materials*/pharmacology , Biocompatible Materials*/chemical synthesis , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemical synthesis , Particle Size*, Animals ; Mice ; Humans ; Cell Line, Tumor ; Drug Screening Assays, Antitumor ; Female ; Cell Survival/drug effects ; Cell Proliferation/drug effects ; Acrylic Resins/chemistry ; Mice, Inbred BALB C

المؤلفون: Fang W; Sun Yat-sen University Cancer Center, Guangzhou, China., Zhao Y; Sun Yat-sen University Cancer Center, Guangzhou, China., Luo Y; Hunan Cancer Hospital, Changsha, China., Yang R; Yunnan Cancer Hospital, Kunming, China., Huang Y; Sun Yat-sen University Cancer Center, Guangzhou, China., He Z; Fujian Provincial Tumor Hospital, Fuzhou, China., Zhao H; The Second Hospital of Anhui Medical University, Hefei, China., Li M; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Li K; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China., Song Q; Renmin Hospital of Wuhan University, Wuhan, China., Du X; Mianyang Central Hospital, Mianyang, China., Sun Y; Shandong Cancer Prevention and Treatment Institute, Jinan, China., Li W; The First Affiliated Hospital of Bengbu Medical University, Bengbu, China., Xu F; The First Affiliated Hospital of Nanchang University, Nanchang, China., Wang Z; The Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Yang K; Weifang No. 2 People's Hospital, Weifang, China., Fan Y; Zhejiang Cancer Hospital, Hangzhou, China., Liu B; Harbin Medical University Cancer Hospital, Harbin, China., Zhao H; Sun Yat-sen University Cancer Center, Guangzhou, China., Hu Y; Beijing Chest Hospital, Capital Medical University, Beijing, China., Jia L; Yuncheng Central Hospital of Shanxi Province, Yuncheng, China., Xu S; Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, China., Yi T; Xiangyang Central Hospital, Xiangyang, China., Lv D; Taizhou Municipal Hospital, Taizhou, China., Lan H; Sichuan Provincial People's Hospital, Chengdu, China., Li M; Army Medical Center of Chinese People's Liberation Army, Chongqing, China., Liang W; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Wang Y; West China Hospital of Sichuan University, Chengdu, China., Yang H; The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China., Jia Y; Yibin Second People's Hospital, Yibin, China., Chen Y; Tongji Hospital of Tongji Medical College of Hust, Wuhan, China., Lu J; Nantong Tumor Hospital, Nantong, China., Feng J; Jiangsu Cancer Hospital, Nanjing, China., Liu C; Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China., Zhou M; Affiliated Cancer Hospital and Institution of Guangzhou Medical University, Guangzhou, China., Zhou J; The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Liu X; The Second Xiangya Hospital of Central South University, Changsha, China., Zhou N; Sun Yat-sen University Cancer Center, Guangzhou, China., He M; The Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Dong X; Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China., Chen H; Affiliated Hospital of Guangdong Medical University, Guangzhou, China., Chen Y; Hainan General Hospital, Haikou, China., Su H; Tangdu Hospital of the Fourth Military Medical University, Xi'an, China., Li X; Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, Shenyang, China., Zhang Z; Anhui Provincial Cancer Hospital, Hefei, China., Yang L; Gansu Provincial Cancer Hospital, Lanzhou, China., Cheng Y; Jilin Cancer Hospital, Changchun, China., Chen L; Sun Yat-sen University Cancer Center, Guangzhou, China., Hou X; Sun Yat-sen University Cancer Center, Guangzhou, China., Zhang Y; Nanjing Chest Hospital, Nanjing, China., Guo J; Xingtai People's Hospital, Xingtai, China., Wang Z; Linyi Cancer Hospital, Linyi, China., Lu H; Huaihe Hospital of Henan University, Kaifeng, China., Wu D; Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital (First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University), Shenzhen, China., Feng W; The First People's Hospital of Foshan, Foshan, China., Li W; The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China., Huang J; The First Affiliated Hospital of Soochow University, Suzhou, China., Wang Y; General Hospital of Ningxia Medical University, Yinchuan, China., Song X; Shanxi Cancer Hospital, Taiyuan, China., Peng J; Zhongshan City People's Hospital, Zhongshan, China., Liu L; Nanfang Hospital Nanfang Medical University, Guangzhou, China., Guo Y; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Li W; Akeso Biopharma, Inc, Zhongshan, China., Lu D; Akeso Biopharma, Inc, Zhongshan, China., Hu M; Akeso Biopharma, Inc, Zhongshan, China., Wang ZM; Akeso Biopharma, Inc, Zhongshan, China., Li B; Akeso Biopharma, Inc, Zhongshan, China., Xia M; Akeso Biopharma, Inc, Zhongshan, China., Zhang L; Sun Yat-sen University Cancer Center, Guangzhou, China.

مؤلفون مشاركون: HARMONi-A Study Investigators

المصدر: JAMA [JAMA] 2024 Aug 20; Vol. 332 (7), pp. 561-570.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Carboplatin*/administration & dosage , Carboplatin*/adverse effects , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/mortality , ErbB Receptors*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , Pemetrexed*/administration & dosage , Pemetrexed*/adverse effects , Progression-Free Survival*, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Double-Blind Method ; Intention to Treat Analysis ; Mutation ; Antibodies, Bispecific/administration & dosage ; Antibodies, Bispecific/adverse effects

المؤلفون: Karatkevich D; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Losmanova T; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Zens P; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Deng H; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland.; 2nd Department of Thoracic Surgery, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.; Hunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China., Dubey C; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland., Zhang T; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Casty C; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland., Gao Y; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland., Neppl C; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.; Institute of Pathology, Heinrich-Heine University and University Hospital of Duesseldorf, Duesseldorf, Germany., Berezowska S; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Wang W; 2nd Department of Thoracic Surgery, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.; Hunan Clinical Medical Research Center of Accurate Diagnosis and Treatment for Esophageal Carcinoma, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China., Peng RW; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland. renwang.peng@insel.ch.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland. renwang.peng@insel.ch., Schmid RA; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland. ralph_a_schmid@hotmail.com.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland. ralph_a_schmid@hotmail.com., Dorn P; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland. patrick.dorn@insel.ch.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland. patrick.dorn@insel.ch., Marti TM; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Murtenstrasse 28, 3008, Bern, Switzerland. thomas.marti@insel.ch.; Oncology-Thoracic Malignancies, Department for BioMedical Research, University of Bern, Bern, Switzerland. thomas.marti@insel.ch.

المصدر: Scientific reports [Sci Rep] 2024 Aug 06; Vol. 14 (1), pp. 18206. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Capecitabine*/pharmacology , Mesothelioma, Malignant*/drug therapy , Mesothelioma, Malignant*/metabolism , Mesothelioma, Malignant*/pathology , Cytidine Deaminase*/metabolism , Cytidine Deaminase*/genetics , Pemetrexed*/pharmacology , Pleural Neoplasms*/drug therapy , Pleural Neoplasms*/metabolism , Pleural Neoplasms*/pathology , Xenograft Model Antitumor Assays*, Humans ; Animals ; Cell Line, Tumor ; Mice ; Cisplatin/pharmacology ; Cisplatin/therapeutic use ; Lung Neoplasms/drug therapy ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Epithelial-Mesenchymal Transition/drug effects ; Mesothelioma/drug therapy ; Mesothelioma/metabolism ; Mesothelioma/pathology ; Female ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Gene Expression Regulation, Neoplastic/drug effects

المؤلفون: Sezgin Y; Department of Medical Oncology, Van Yuzuncu Yil University, Van, Turkiye.; Department of Medical Oncology, Harran University, Sanliurfa, Turkiye.; Department of Medical Oncology, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkiye.; Department of Medical Oncology, Dicle University Hospital, Diyarbakir, Turkiye., Karhan O, Ileri S, Ebinc S, Tunc S, Urakci Z; Department of Medical Oncology, Van Yuzuncu Yil University, Van, Turkiye.; Department of Medical Oncology, Harran University, Sanliurfa, Turkiye.; Department of Medical Oncology, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkiye.; Department of Medical Oncology, Dicle University Hospital, Diyarbakir, Turkiye.

المصدر: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP [J Coll Physicians Surg Pak] 2024 Aug; Vol. 34 (8), pp. 904-909.

نوع المنشور: Journal Article; Observational Study; Comparative Study; Validation Study

بيانات الدورية: Publisher: College of Physicians and Surgeons Pakistan Country of Publication: Pakistan NLM ID: 9606447 Publication Model: Print Cited Medium: Internet ISSN: 1681-7168 (Electronic) Linking ISSN: 1022386X NLM ISO Abbreviation: J Coll Physicians Surg Pak Subsets: MEDLINE

مواضيع طبية MeSH: Pemetrexed*/therapeutic use , Pemetrexed*/administration & dosage , Cisplatin*/therapeutic use , Cisplatin*/administration & dosage , Gemcitabine* , Mesothelioma, Malignant*/drug therapy , Pleural Neoplasms*/drug therapy , Pleural Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Deoxycytidine*/analogs & derivatives , Deoxycytidine*/therapeutic use , Deoxycytidine*/administration & dosage, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Prognosis ; Aged ; Adult ; Progression-Free Survival

المؤلفون: Luukkainen MEK; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.; Medical Research Center Oulu, Oulu, Finland.; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland., Koivunen JP; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland; jussi.koivunen@pohde.fi.; Medical Research Center Oulu, Oulu, Finland.; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.

المصدر: Anticancer research [Anticancer Res] 2024 Jul; Vol. 44 (7), pp. 2805-2813.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Anaplastic Lymphoma Kinase*/antagonists & inhibitors , Anaplastic Lymphoma Kinase*/genetics , Anaplastic Lymphoma Kinase*/metabolism , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Protein Kinase Inhibitors*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Cisplatin*/pharmacology , Cisplatin*/administration & dosage , Pemetrexed*/pharmacology , Pemetrexed*/administration & dosage, Humans ; Cell Line, Tumor ; Apoptosis/drug effects ; Drug Synergism ; Drug Resistance, Neoplasm/drug effects ; Receptor Protein-Tyrosine Kinases/antagonists & inhibitors ; Receptor Protein-Tyrosine Kinases/genetics ; Receptor Protein-Tyrosine Kinases/metabolism ; Piperidines/pharmacology ; Piperidines/administration & dosage ; Carbazoles/pharmacology ; Carbazoles/administration & dosage

المؤلفون: Saw SPL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore. Electronic address: stephanie.saw.p.l@singhealth.com.sg., Low YF; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Lai GGY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Chan LL; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China., Wong WKY; Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China., Tsui G; Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China., Chen OH; Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China., Seet AOL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Tan WC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Chan JWK; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Teh YL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Tan WL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Ng QS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Ang MK; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Lim DWT; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Tan DSW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore., Mok TSK; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China., Li MSC; Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Jul; Vol. 193, pp. 107856. Date of Electronic Publication: 2024 Jun 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Acrylamides*/therapeutic use , Aniline Compounds*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/pathology , ErbB Receptors*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , Lung Neoplasms*/pathology , Mutation* , Pemetrexed*/therapeutic use , Pemetrexed*/administration & dosage, Female ; Humans ; Male ; Middle Aged ; Disease Progression ; Indoles ; Platinum/therapeutic use ; Platinum/administration & dosage ; Pyrimidines ; Retrospective Studies ; Treatment Outcome

المؤلفون: Jia G; Oncology Department, First Affiliated Hospital of Jinan University., Bashir S; Oncology Department, Guangdong Sanjiu Brain Hospital, Guangzhou, China., Ye M; Oncology Department, Guangdong Sanjiu Brain Hospital, Guangzhou, China., Li Y; Oncology Department, First Affiliated Hospital of Jinan University., Lai M; Oncology Department, Guangdong Sanjiu Brain Hospital, Guangzhou, China., Cai L; Oncology Department, Guangdong Sanjiu Brain Hospital, Guangzhou, China., Xu M; Oncology Department, First Affiliated Hospital of Jinan University.

المصدر: Anti-cancer drugs [Anticancer Drugs] 2024 Jul 01; Vol. 35 (6), pp. 542-547. Date of Electronic Publication: 2024 Mar 15.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Pemetrexed*/administration & dosage , Pemetrexed*/therapeutic use , ErbB Receptors*/genetics , Acrylamides*/administration & dosage , Acrylamides*/therapeutic use , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Aniline Compounds*/administration & dosage , Aniline Compounds*/therapeutic use , Mutation* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Male ; Middle Aged ; Injections, Spinal ; Meningeal Carcinomatosis/drug therapy ; Meningeal Carcinomatosis/secondary ; Meningeal Carcinomatosis/genetics ; Meningeal Neoplasms/secondary ; Meningeal Neoplasms/drug therapy ; Meningeal Neoplasms/genetics ; Indoles ; Pyrimidines